• Andrij Vergun Danylo Halytsky Lviv National Medical University, Lviv, Ukraine
  • Mykhaylo Krasnyj Danylo Halytsky Lviv National Medical University, Lviv, Ukraine
  • Zoryana Kit Danylo Halytsky Lviv National Medical University, Lviv, Ukraine
  • Oksana Vergun Danylo Halytsky Lviv National Medical University, Lviv, Ukraine
Keywords: polyonychomycosis, ingrown nail, type 2 diabetes mellitus, metabolic syndrome, lipid exchange disturbances, insulin-resistance


The study involves peculiarities of treatment, some indicators of lipid exchange in patients with diabetes mellitus, metabolic syndrome accompanied by destructive onychomycosis and secondary ingrown nail. Clinical options of in-patient and outpatient surgical treatment for nail ingrowth (mono-lesions; complicated and combined mycotic-associated processes and relapses) were clarifi ed; morphologic changes were studied; causes of unsatisfactory outcomes of chronic pathology complex treatment were analyzed for prospective approaches to preventing relapses. Along with antimycotic therapy and correction of comorbid pathology the following procedures were carried out: cutting pathologic eponychial tissues, hypergranulations and necroses; removing nail plate with partial marginal matrixectomy in the ingrowth area. Non-invasive methods of nail excision and marginal nail resection were preferred in patients with diabetes mellitus. The prospective study involved 403 patients (48-72 aged) with complicated mycotic damage, nail ingrowth. Polyonychomycosis and trichophytic subungual hyperkeratosis with secondary ingrown nail were diagnosed in the main group comprising 62 patients with type 2 diabetes mellitus (48 males and 14 females, 42-65 aged). Metabolic syndrome was confi rmed in the comparison group comprising 53 patients with arterial hypertension and complicated mycotic nail damage. The rest 276 patients made up the control group. We studied biochemical indicators, lipid blood spectrum: total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol; nitric oxide of blood plasma; leptin. Lipid blood spectrum and nitric oxide level were determined before and after pharmacotherapy along with continuous antihypertensive therapy (correction of intercurrent and comorbid pathology). The objective criterion of insulin resistance was NOMA-IP index (the Homeostasis Model Assessment) involving glucose and insulin levels on an empty stomach divided by 22,5 coeffi cient. Patients of the main and the comparison groups with polyohychomycosis and trichophytic subungual hyperkeratosis with secondary nail ingrowth experienced considerable decreasing NOMA-index of β-cells function and increasing NOMAindex of insulin resistance (8,11±1,1 in the main group, 5,89±2,1 in the comparison group and 2,23±1,18 in the control group, p1<0,01; p2<0,01). Considerable positive correlation between all indicators of carbohydrate exchange was identifi ed in groups comprising patients with type2 diabetes mellitus: glucose and insulin (r=0,51; p<0,01), with NOMA-index (r=0,70; p<0,01), with glycolyzed hemoglobin (r=0,75; p<0,001); insulin with NOMA-index (r=0,73; p<0,01) and glycolyzed hemoglobin (r=0,65; p<0,01); NOMA-index with glycolyzed hemoglobin (r=0,67; p<0,01). Considerable increasing of circulating insulin was identifi ed directly after surgical treatment (in the main group and the comparison group correspondingly 15,33±1,12 and 8,24±1,18 mkMO/l, p<0,01), NOMA-index of insulin resistance (p<0,05) and NOMA-index of β-cells function (p<0,05) in comparison with the control group with further tendency to some decrease in the process of treatment. We determined disturbances in lipid exchange, insulin resistance, lipid blood spectrum changes that were considerably higher in both groups of patients (main and comparison groups), p<0,01 for both groups in comparison with the control group.


Download data is not yet available.


Baran R, Feuilhade M, Datry A, Goettmann S, Pietrini P, Viguie C, Badillet G, Larnier C, Czernielewski J. A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region. British Journal of Dermatology. 2000 Jun 1;142(6):1177-83.

Chernysheva EN. Rol insulinorezistentnosti v razvitii prezhdevremennogo stareniya u patsientov s metabolicheskim sindromom [Role of insulin resistance in the development of premature aging in patients with metabolic syndrome] Sovremennyie issledovaniya sotsialnyih problem (elektronnyiy nauchnyiy zhurnal). 2013. 9(29), Retrieved from URL.

DeSouza CA, Guilder GP, Greiner JJ, Smith DT, Hoetzer GL, Stauffer BL. Basal endothelial nitric oxide release is preserved in overweight and obese adults. Obesity. 2005 Aug 1;13(8):1303-6.

Emelyanov YuF. O porazhenii nogtevyih plastinok [The defeat of the nail plate].Voenno-meditsinskiy zhurnal. 1984 (3):68-69.

Gamboa A, Shibao C, Diedrich A, Choi L, Pohar B, Jordan J, Paranjape S, Farley G, Biaggioni I. Contribution of endothelial nitric oxide to blood pressure in humans. Hypertension. 2007 Jan 1;49(1):170-7.

Havu V, Heikkilä H, Kuokkanen K, Nuutinen M, Rantanen T, Saari S, Stubb S, Suhonen R, Turjanmaa K. A double‐blind, randomized study to compare the efficacy and safety of terbinafine (Lamisil®) with fluconazole (Diflucan®) in the treatment of onychomycosis. British Journal of Dermatology. 2000 Jan 1;142(1):97-102.

Yang KC, Li YT. Treatment of recurrent ingrown great toenail associated with granulation tissue by partial nail avulsion followed by matricectomy with sharpulse carbon dioxide laser. Dermatologic surgery. 2002 May 1;28(5):419-21.

Yin Z, Xu J, Luo D. A meta-analysis comparing long-term recurrences of toenail onychomycosis after successful treatment with terbinafine versus itraconazole. Journal of Dermatological Treatment. 2012 Dec 1;23(6):449-52.

Kit ZM. Porivnjalna otsinka lipidnoho spektru krovi, L-arhininu, oksydu azotu ta leptynu u patsijentiv z arterialnoju hipertenzijeju na foni ozhyrinnja ta bez njoho [Comparative assessment of lipid spectrum of the blood, L-arginine, nitric oxide and leptin in patients with hypertension and obesity in the background without him]. Eksperymentalna ta klinichna fi ziolohiia i biokhimiia. 2008 (1):56-59.

Kit ZM. Stan dejakykh kliniko-laboratornykh pokaznykiv u khvorykh na arterialnu hipertenziju z suputnim ozhyrinnjam ta IHS [Status of certain clinical and laboratory parameters in patients with arterial hypertension with concomitant obesity and ischemic heart disease]. Praktychna medytsyna. 2005. 11(2):72-75.

Kochev KN. (ed.). Zabolevaniya i povrezhdeniya stop i ih lechenie [Diseases and injuries of the foot and their treatment] Medicina. Moskva 1953.

Kotyk VV, Verhun AR. Onikhomikoz stopy: etiolohichne ta patohenetychne obhruntuvannja dejakykh khirurhichnykh aspektiv kompleksnoho likuvannia [Onychomycosis of the foot: etiological and pathogenetic substantiation of some aspects of surgical aspects of complex treatment]. Praktychna medytsyna. 2005. 11(3):27- 33.

Meleshevich AV, Meleshevich (ed) Hirurgicheskioe lechenie vrosshego nogtya (rukovodstvo dlya hirurgov) [Surgical treatment of ingrown nail (guide for surgeons)] Grodno. 1993.

Serheev AYu. Novaya koncepcyya patoheneza onyxomykozov. Vestn. dermatol. 2001(5):8-11.

Sergeev AYu, Sergeev YuV. Onihomikozy: na puti k resheniyu problemy [Onychomycosis: on the way to solving the problem]. Consilium Medicum. 2003. 5(3):128—135.

Tkachenko GK. Lechenie vrosshego nogtya [Treatment of ingrown nail]. Zdravoohranenie Kazahstana. 1981 (11):58-59.

Verhun AR. Polietiolohichni pojednani urazhennia nihtja: analiz klinichnykh sposterezhenj ta osoblyvostej ambulatornoho khirurhichnoho likuvannja [Polyetiological connected nail pathology: clinical observations and analysis features ambulatory surgical treatment]. Acta Medica Leopoliensia. 2005. 11(1):64–66.

Verhun AR, Kotyk VV. Zastosuvannja serratsiopeptydazy v kompleksnomu likuvanni khvorykh na trykhofi tiinyj pidnihtjovyj hiperkeratoz, uskladnenyj vroslym nihtem [Application of serraciopeptydasa in complex treatment of patients with trichofi tial subungual hyperkeratosis complicated ingrown nails]. Shpytalna khirurhiia. 2006. (2):36–39.

Abstract views: 126
PDF Downloads: 67 PDF Downloads: 0
How to Cite
Vergun A, Krasnyj M, Kit Z, Vergun O. MYCOSIS-INDUCED NAIL INGROWTH IN PATIENTS WITH DIABETES MELLITUS AND METABOLIC SYNDROME: APPROACHES TO THE PROBLEM. Proc Shevchenko Sci Soc Med Sci [Internet]. 2016Jul.20 [cited 2023Jun.1];280:108-20. Available from: